Cancer clinical trials in the region Hauts-de-France
105 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Breast cancer
#NCT06016738
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Targeted therapy
Hormone therapy
Chemotherapy
Centre Hospitalier de Compiègne (Compiègne), Centre Hospitalier Universitaire de Nantes (Nantes), Centre Jean Perrin (Clermont Ferrand ), Gustave Roussy (Villejuif), Centre Hospitalier du Mans (Le Mans) (and 1 more...)
Olema Pharmaceuticals, Inc.
Phase 3
Lung cancer
#NCT06267001
NSCLC (Non-Small Cell Lung Cancer)
Localized
Locally Advanced
Surgery
Chemotherapy
Surgery
Chemotherapy
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
EGFR
ALK
Systemic Treatment-Naive
Systemic Treatment-Naive
Clinique Teissier - Valenciennes (Valenciennes)
Hoffmann-La Roche
Phase 3
Pancreas cancer
#NCT04167007
Adenocarcinoma
Metastatic
Systemic Treatment-Naive
Hôpital privé Arras les Bonnettes - Ramsay Santé (Arras), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
Assistance Publique - Hôpitaux de Paris
Phase 3
Lymphoma
#NCT05578976
B cell lymphoma
Large B cell lymphoma
Follicular lymphoma
CD20
Systemic Treatment-Naive
None
Hôpital Saint Louis AP-HP (Paris), Institut Paoli-Calmettes (Marseille), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Grenoble (La Tronche), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 16 more...)
Abbvie
Phase 3
Lymphoma
#NCT05605899
B cell lymphoma
Large B cell lymphoma
None
Systemic Treatment-Naive
None
Hôpital Henri-Mondor AP-HP (Créteil), CHU de Rennes - Hôpital Pontchaillou (Rennes), Hôpital Claude Huriez (Lille), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier)
Kite, A Gilead Company
Phase 3
Colon cancer
Rectal cancer
#NCT06293625
Adenocarcinoma
Locally Advanced
MSS
Systemic Treatment-Naive
MSI/dMMR
Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg (Strasbourg), Centre Hospitalier Intercommunal Elbeuf - Louviers - Val de Reuil (Saint-Aubin-lès-Elbeuf), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Hôpital Jacques Puel - Bourran (Rodez) (and 56 more...)
CHU Dijon
Phase 3
Lymphoma
#NCT06084936
B cell lymphoma
Mantel cell lymphoma
None
1
2
3 or more
Systemic Treatment-Naive
Car-T
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Institut Curie - Paris (Paris), Hôpital Necker Enfants malades - AP-HP (Paris )
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT06018337
HER2 Low
HR Positive
Locally Advanced
Metastatic
Targeted therapy
Hormone therapy
Chemotherapy
Antibody Drug Conjugates (ADC)
Hôpital Henri-Mondor AP-HP (Créteil), CHU Nîmes / Institut de cancérologie du Gard (Nîmes), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire Dupuytren (Limoges) (and 11 more...)
DualityBio Inc.
Phase 3
Lung cancer
#NCT06012435
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
CHU - Haut-lévêque - Bordeaux (Pessac), Hôpital Bichat - Claude Bernard - AP-HP (Paris), Centre Hospitalier Universitaire de Toulouse (Toulouse), Centre Hospitalier Universitaire de Lille (Lille), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 10 more...)
Seagen
Phase 3
Lymphoma
#NCT06006117
B cell lymphoma
Marginal zone lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
Targeted therapy
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier Régional d'Orléans Hôpital de La Source (Orléans), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Antoine Lacassagne (Nice), CHU Nice Hôpital l'Archet (Nice) (and 18 more...)
Organisation de recherche universitaire sur le lymphome